| 02/06 | Pfizer Moves to Check High Prevalence of Stroke in Nigeria | AQ |
| 01/06 | Phase 3 Studies of Pfizer's Novel Antibiotic Combination Offer New Treatment Hope for P.. | BU |
| 01/06 | U.S. FDA Approves ABRYSVO, Pfizer's Vaccine for the Prevention of Respiratory Syncytial.. | AQ |
| 01/06 | Coeptis Therapeutics Shares Rally 59% In May, Here's Why The Increase Is An Expected Pr.. | AQ |
| 01/06 | FDA approves second RSV vaccine for people older than 60 | AQ |
| 31/05 | U.S. FDA Approves ABRYSVO™, Pfizer's Vaccine for the Prevention of Respiratory Sy.. | BU |
| 30/05 | Covid-19 - What Next As Shots Expire and Become Harder to Get? | AQ |
| 30/05 | Coeptis Therapeutics Shares Rally 67% In May, Clinical Interests And Planned Acquisitio.. | AQ |
| 30/05 | Pfizer Announces Positive Marstacimab Results from Pivotal Phase 3 Hemophilia A and B T.. | BU |
| 26/05 | Astellas Highlights Continued Delivery of Strong Cancer Portfolio and Pipeline at 2023 .. | AQ |
| 26/05 | Pfizer's PAXLOVID Receives FDA Approval for Adult Patients at High Risk of Progression .. | AQ |
| 25/05 | Pfizer Presents Scientific Advancements from its Leading Oncology Portfolio at ASCO 202.. | BU |
| 25/05 | COVID pill Paxlovid gets full FDA approval after more than a year of emergency use | AQ |
| 25/05 | FDA approves Pfizer's Paxlovid for COVID-19 treatment | AQ |
| 25/05 | Pfizer's PAXLOVID™ Receives FDA Approval for Adult Patients at High Risk of Progr.. | BU |
| 24/05 | Pfizer/Seagen And What May Follow | AQ |
| 24/05 | Harbinger Health Appoints May Orfali, M.D. as Chief Medical Officer | AQ |
| 19/05 | FDA Advisory Committee Votes in Support of Approval for Pfizer's Vaccine Candidate to H.. | AQ |
| 18/05 | FDA advisers back RSV vaccine for pregnant women that protects their newborns | AQ |
| 18/05 | FDA Advisory Committee Votes in Support of Approval for Pfizer's Vaccine Candidate to H.. | BU |
| 17/05 | IDEAYA Biosciences Expands Clinical Trial Collaboration and Supply Agreements with Pfiz.. | AQ |
| 17/05 | Press Release - 16/05/2023 | AQ |
| 17/05 | Pfizer Prices $31,000,000,000 Debt Offering | BU |
| 16/05 | Pfizer Announces Proposed Notes Offering | AQ |
| 16/05 | IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer to Suppor.. | PR |
| 15/05 | TILT Biotherapeutics Announces First Patient Dosed in Phase I Solid Tumors Trial Assess.. | AQ |
| 15/05 | Press Release - 15/05/2023 | AQ |
| 15/05 | Pfizer Announces Proposed Notes Offering | BU |
| 15/05 | Pfizer Inc : Other Events (form 8-K) | AQ |
| 15/05 | France Economy Macron | AQ |
| 12/05 | Aptevo Therapeutics Reports 1Q23 Financial Results and Provides Business Update | AQ |
| 10/05 | Thinking about trading options or stock in Apple, Microsoft, Advanced Micro Devices, Pf.. | PR |
| 09/05 | Antibody response varies for Big Pharma COVID vaccines | AQ |
| 09/05 | BIONTECH moves on from Covid-19 with search for new vaccinations | AQ |
| 08/05 | New RSV Vaccine Can Save Thousands of Lives, Researchers Say | AQ |
| 08/05 | Kraft Heinz Announces Humberto Alfonso as New Independent Board Member; CPG Industry Ve.. | AQ |
| 08/05 | Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentations at th.. | AQ |
| 02/05 | Pfizer tops Q1 forecasts; vaccine sales slide as expected | AQ |
| 02/05 | Pfizer Reports First-Quarter 2023 Results - 02/05/2023 | AQ |
| 02/05 | Gambia Receives 149,760 COVID-19 Vaccines From Italy | AQ |
| 02/05 | Pfizer : Q1 Earnings Snapshot | AQ |
| 02/05 | Pfizer : First Quarter 2023 Press Release | PU |
| 02/05 | Pfizer Reports First-Quarter 2023 Results | BU |
| 02/05 | Advancements In Candidemia Research : A Look at the Most Promising Candidemia Pipeline Com.. | AQ |
| 01/05 | Astellas Pharma Inc. - XTANDI plus Leuprolide Reduced the Risk of Metastasis by 58% in .. | AQ |
| 01/05 | Department of Energy - Making Medical History the Development of the First Oral Treatme.. | AQ |
| 01/05 | Pfizer Inc : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
| 28/04 | Pfizer Announces 2023 Shareholder Meeting Preliminary Results | AQ |
| 28/04 | U.S. FDA Approves PREVNAR 20, Pfizer's 20-valent Pneumococcal Conjugate Vaccine for Inf.. | AQ |
| 27/04 | U.S. FDA Approves PREVNAR 20®, Pfizer's 20-valent Pneumococcal Conjugate Vaccine for In.. | BU |
| 27/04 | Research Critical to Vaccines Development - Pfizer | AQ |
| 26/04 | Pfizer Declares Second-Quarter 2023 Dividend | BU |
| 26/04 | Myrtelle's rAAV-Olig001-ASPA Gene Therapy Candidate for Canavan Disease Receives Innova.. | AQ |
| 26/04 | World Immunisation Week 2022 - Firm Seeks Post-Covid-19 Catch-Up Against Vaccine-Preven.. | AQ |
| 25/04 | Vaccines Do Not Cause Magnetism, No Evidence Government Is 'Secretly Injecting the Vacc.. | AQ |
| 24/04 | AM Best Affirms Credit Ratings of Blue Whale Re Ltd | AQ |
| 21/04 | AM Best Affirms Credit Ratings of Blue Whale Re Ltd. | BU |
| 21/04 | REMICADE Antitrust Settlement Receives Final Approval | AQ |
| 20/04 | No Graphene Oxide in Covid-19 Vaccines, Pfizer Document Taken Out of Context | AQ |
| 18/04 | FDA clears extra COVID booster for some high-risk Americans | AQ |
| 18/04 | Extra COVID-19 booster now open to some high-risk Americans | AQ |
| 17/04 | Update On Arbutus MRNA Vaccine Patent Litigations | AQ |
| 14/04 | Haemophilia - Health Experts Advocate Proper Diagnosis, Management in Africa | AQ |
| 13/04 | Pfizer Invites Shareholders to Attend Virtual-Only 2023 Annual Meeting of Shareholders .. | BU |
| 10/04 | Pfizer : Ads & Social Media – 2023 Annual Meeting | PU |
| 10/04 | Seagen to Report First Quarter 2023 Financial Results on April 27, 2023 | AQ |
| 05/04 | Pfizer Inc - FDA Accepts Pfizer's Supplemental New Drug Applications for BRAFTOVI + MEK.. | AQ |
| 05/04 | Arbutus Biopharma and Genevant Sciences File Patent Infringement Lawsuit against Pfizer.. | AQ |
| 04/04 | FDA Accepts Pfizer's Supplemental New Drug Applications for BRAFTOVI + MEKTOVI | BU |
| 03/04 | Pfizer Expands Cancer Drug Portfolio With $43 Billion Biotech Acquisition Subscribe | AQ |
| 30/03 | Medicines Patent Pool signs sublicences with Aurobindo, Cipla and Viatris to produce ge.. | AQ |
| 29/03 | Japan Had Weak Basis For Ordering 88 : audit | AQ |
| 28/03 | Merck Strengthens Oncology Franchise by Securing Exclusive Worldwide Rights to Anti PD-.. | AQ |
| 23/03 | Analysts Model Over 74% Upside For Mainz Biomed Stock Ahead Of Key 1/H 2023 Updates (.. | AQ |
| 22/03 | Senators press Moderna CEO on COVID-19 vaccine price hike | AQ |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
